Semaglutide's weight-loss case strengthens as a real-world eye-safety signal draws scrutiny
Read the Sunday Brief →

Study wrapper · #1121

AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice.

d'Ávila M, Cavalcanti-de-Albuquerque J, Collado-Pérez R, et al. Proceedings of the National Academy of Sciences of the United States of America. 2026.
SupportedAnimal (in vivo)Mentions: Semaglutide

Editor's note

This inverts a standing assumption about how incretins act centrally: the hunger-promoting neurons appear to be recruited rather than silenced, and the full weight effect depends on them. The sex-dependence is notable given the work was done in female mice and the authors report the requirement varies with sex and diet. Mouse circuit neuroscience does not transfer directly to human dosing, but it points at why long-term response may be shaped by adaptive rather than purely suppressive mechanisms.

Plain-language abstract

Working in female mice, researchers tested whether AgRP neurons in the arcuate nucleus are needed for GLP-1 receptor agonists such as semaglutide to lower body weight. AgRP neurons normally drive hunger, so the expectation was that these drugs suppress or bypass them. Instead, disrupting AgRP circuits blunted the full weight-lowering effect, and GLP-1 agonist exposure increased markers of neuronal activation, mitochondrial engagement, and synaptic remodelling in those neurons. A glucocorticoid-to-AgRP signalling axis appeared to mediate the recruitment, with effects varying by sex, diet, and how the circuit was disrupted.